PC

PSQ Capital

North America, New York, United States, New York

Description

PSQ Capital is a family investment office in New York City.

Investor Profile

PSQ Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PSQ Capital frequently co-invest with?

Capital Community Angel Investors
North America, Michigan, United States, East Lansing
Co-Investments: 2
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 2
AV
North America, South Carolina, United States, Charleston
Co-Investments: 1
Michigan Capital Network
North America, Michigan, United States, Grand Rapids
Co-Investments: 1
M
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
Bios Partners
North America, Texas, United States, Fort Worth
Co-Investments: 2
Biosciences Research and Commercialization Center (BRCC)
North America, Michigan, United States, Kalamazoo
Co-Investments: 2
MC
North America, Pennsylvania, United States, Pennsylvania Furnace
Co-Investments: 1
Kaitai Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 2

What are some of recent deals done by PSQ Capital?

ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 22, 2020
Amount Raised: $46,900,000